Skip to main content

Table 4 Associations between liver fibrosis indices and substantial HE in patients within 6 h of onset (n = 200)

From: Liver fibrosis indices associated with substantial hematoma expansion in Chinese patients with primary intracerebral hemorrhage

Index Odds ratio (95% confidence interval); p-value
Model 1 Model 2
APRI 2.634 (1.299-5.341); p = 0.007 2.641 (1.303-5.356); p = 0.007
AARPRI 1.526 (1.081-2.156); p = 0.016 1.553 (1.093-2.207); p = 0.014
FIB-4 1.336 (1.071-1.667); p = 0.010 1.345 (1.077-1.679); p = 0.009
mFIB-4 1.084 (1.003-1.170); p = 0.041 1.088 (1.006-1.177); p = 0.034
FibroQ 1.076 (1.001-1.156); p = 0.048 1.080 (1.003-1.163); p = 0.042
Forns index 1.365 (1.104-1.689); p = 0.004 1.366 (1.104-1.689); p = 0.004
  1. Abbreviations: APRI AST-platelet ratio index, AARPRI AAR/platelet ratio index, where AAR is aspartate aminotransferase/alanine aminotransferase (AST/ALT) ratio, FIB-4 fibrosis-4, mFIB-4 modified fibrosis-4, FibroQ fibrosis quotient, ICH intracerebral hemorrhage, CI confidence interval
  2. Model 1 was adjusted for age, sex and hematoma location
  3. Model 2 was adjusted for the same variables as Model 1, as well as baseline hematoma volume